Pharming Group NV (PHAR) — Financial Flexibility Index
Pharming Group NV (PHAR) has a Financial Flexibility Index of 0.01x as of March 2026. Free cash flow of $1.87 Million (operating CF $1.63 Million minus capex $238.86K) represents 0% of total liabilities ($220.41 Million). Also explore Pharming Group NV (PHAR) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pharming Group NV Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Pharming Group NV across 21 annual periods. Check how strategically is Pharming Group NV's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Pharming Group NV (2005–2025)
Year-by-year free cash flow to debt coverage for Pharming Group NV. For the full company profile including market capitalisation, see PHAR market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | $50.82 Million | $50.07 Million | $222.79 Million | ▲ +4185.1% |
| 2024 | -0.01x | $-999.00K | $-1.79 Million | $178.92 Million | ▲ +91.4% |
| 2023 | -0.06x | $-15.84 Million | $-17.30 Million | $244.07 Million | ▼ -158.7% |
| 2022 | 0.11x | $24.43 Million | $22.46 Million | $221.16 Million | ▼ -58.6% |
| 2021 | 0.27x | $54.56 Million | $37.84 Million | $204.40 Million | ▼ -48.1% |
| 2020 | 0.51x | $98.93 Million | $83.63 Million | $192.39 Million | ▼ -28.5% |
| 2019 | 0.72x | $99.60 Million | $74.15 Million | $138.53 Million | ▲ +148.9% |
| 2018 | 0.29x | $50.50 Million | $46.19 Million | $174.81 Million | ▼ -3.8% |
| 2017 | 0.30x | $53.10 Million | $45.84 Million | $176.82 Million | ▲ +451.3% |
| 2016 | -0.09x | $-8.93 Million | $-10.52 Million | $104.45 Million | ▲ +81.4% |
| 2015 | -0.46x | $-16.97 Million | $-17.95 Million | $37.00 Million | ▼ -131.6% |
| 2014 | -0.20x | $-6.23 Million | $-6.42 Million | $31.46 Million | ▲ +36.8% |
| 2013 | -0.31x | $-11.42 Million | $-11.45 Million | $36.45 Million | ▲ +20.5% |
| 2012 | -0.39x | $-12.77 Million | $-13.58 Million | $32.40 Million | ▲ +30.3% |
| 2011 | -0.57x | $-18.97 Million | $-20.34 Million | $33.55 Million | ▼ -260.2% |
| 2010 | -0.16x | $-5.68 Million | $-6.89 Million | $36.16 Million | ▲ +64.3% |
| 2009 | -0.44x | $-26.81 Million | $-27.24 Million | $60.99 Million | ▼ -155.2% |
| 2008 | -0.17x | $-13.08 Million | $-14.21 Million | $75.96 Million | ▲ +34.9% |
| 2007 | -0.26x | $-30.71 Million | $-31.69 Million | $116.14 Million | ▲ +53.1% |
| 2006 | -0.56x | $-21.74 Million | $-25.89 Million | $38.59 Million | ▲ +72.6% |
| 2005 | -2.06x | $-14.24 Million | $-15.26 Million | $6.93 Million | — |